期刊文献+

甘精胰岛素与降糖药口服治疗2型糖尿病的效果与价值分析 被引量:4

Effect and value of insulin glargine and oral hypoglycemic drugs in the treatment of type 2 diabetes mellitus
下载PDF
导出
摘要 目的:分析在2型糖尿病患者治疗中,采用甘精胰岛素与降糖药物治疗的临床疗效。方法:收治2型糖尿病患者100例,分两组。对比组患者单用降糖药物口服治疗,观察组患者采用甘精胰岛素与降糖药物治疗,将两组患者血糖指标作为临床疗效的对比依据。结果:将两组患者的血糖指标与低血糖发生率作为临床治疗效果的对比依据,根据研究数据分析,观察组治疗效果显著优异,并与对比组差异有统计学意义(P<0.05)。结论:对2型糖尿病患者采用降糖药口服联合甘精胰岛素治疗,对其血糖指标的控制有积极作用,为有效治疗方案。 Objective:To analyze the clinical efficacy of insulin glargine and hypoglycemic drugs in the treatment of type 2 diabetes mellitus.Methods:100 patients with type 2 diabetes mellitus were selected,they were divided into the two groups.The patients in the control group were treated with hypoglycemic drugs orally,while the patients in the observation group were treated with insulin glargine and hypoglycemic drugs.Results:The blood glucose index and hypoglycemia rate of the two groups were compared as the clinical therapeutic effect.According to the analysis of the study data,the therapeutic effect of the observation group was remarkable,and there was statistical difference between the observation group and the control group(P<0.05). Conclusion:Oral hypoglycemic drugs combined with insulin glargine are effective in the control of blood glucose in type 2 diabetic patients,it is an effective treatment.
作者 胡广周 Hu Guangzhou(Department of Internal Medicine,Yandian Branch of Linqing People's Hospital,Shandong Linqing 252665)
出处 《中国社区医师》 2019年第4期28-28,31,共2页 Chinese Community Doctors
关键词 甘精胰岛素 降糖药 2型糖尿病 应用价值 Insulin glargine Hypoglycemic drugs Type 2 diabetes mellitus Application value
  • 相关文献

参考文献4

二级参考文献29

  • 1Pan C, Yang W, Jia W, et al. Management of Chinese patients with type 2 diabetes, 1998 - 2006 : the Diabcare-China surveys [J]. Curr Med Res Opin,2009,25 ( 1 ) :39 -45.
  • 2Valensi P, Benroubi M, Borzi V, et al. The IMPROVE study-a multinational,observational study in type 2 diabetes:baseline characteristics from eight national cohorts [ J ]. Int J Clin Pract, 2008,62 (11) :1809 -19.
  • 3Cugnet-Anceau C, Bauduceau B. Glycaemic control and cardiovascular morbi-mortality: the contribution of the 2008 studies[J]. Ann Endocrinol(Paris) ,2009,70( 1 ) :48 -54.
  • 4Davies M, Storms F, Shutler S, et al. hnprovement of glycemic control in subjects with poorly controlled type 2 diabetes:comparison of two treatment algorithms using insulin glargine[J].Diabetes Care, 2005,28 (6) : 1282 - 8.
  • 5Bolli GB, Owens DR. Insulin glargine [ J ]. Lancet, 2000, 356 (9228) :443 -5.
  • 6Johansen OE, Vanberg PJ, Kilhovd BK, et al. Changing basal insulin from NPH to detemir or glargine in patients with type 1 diabetes and a history of severe hypoglycemia [J]. Vasc Health Risk Manag, 2009,5(1) :121 -8.
  • 7Dorkhan M, Frid A: Groop L. Differences in effects of insulin glargine or pioglitazone added to oral anti-diabetic therapy in patients with type 2 diabetes:what to add-insulin glargine or pioglitazone [ J ]. Diabetes Res Clin Pract,2008,82 ( 3 ) :340 - 5.
  • 8Bazzano LA, Lee LJ, Shi L, et al. Safety and efficacy of glargine compared with NPH insulin for the treatment of Type 2 diabetes:a meta- analysis of randomized controlled trials [ J ]. Diabet Med, 2008,25 (8) :924 -32.
  • 9De Mattia G, Laurenti O, Moretti A. Comparison of glycaemic control in patients with type 2 diabetes on basal insulin and fixed combination oral antidiabetic treatment:results of a pilot study[ J]. Acta Diabetol,2009,46( 1 ) :67 -73.
  • 10邓大同.糖尿病与脂代谢异常[J].安徽医药,2008,12(3):195-198. 被引量:15

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部